Ocrevus®
What is Ocrevus®?
Ocrevus® (ocrelizumab) is a monoclonal antibody approved for the treatment of both relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) in adults. As part of the anti-CD20 therapy class, Ocrevus is designed to selectively target and deplete B cells — immune cells that play a critical role in the nerve damage seen in MS. Ocrevus® offers a powerful treatment option for patients across a broad spectrum of MS, helping to slow disease progression and reduce relapses, with a well-established safety profile.
How does Ocrevus® work?
In multiple sclerosis (MS), the immune system mistakenly attacks the myelin sheath — the insulating layer around nerves in the brain and spinal cord that helps transmit signals efficiently. B cells, which carry a surface protein called CD20, contribute significantly to this autoimmune attack.
When the myelin sheath is damaged, communication between nerve cells breaks down, leading to symptoms like muscle weakness, coordination problems, vision disturbances, and cognitive issues.
Ocrevus® works by targeting the CD20 marker on B cells, helping to eliminate these cells before they can continue fueling inflammation and myelin damage. While Ocrevus is not a cure for MS, it helps to stabilize the immune system, slow disability progression, and reduce new disease activity.
How much does Ocrevus® cost?
Ocrevus® cost can vary depending on several factors including insurance status and insurance provider. Our team at Rocky Mountain MS Clinic are committed to lowering costs and improving access for our patients.
We work with virtually all leading commercial insurance providers in the greater Intermountain region, including Aetna, Anthem, Blue Cross Blue Shield, Cigna, DMBA, EMI Health, Humana, PEHP Health & Benefits, Select Health, as Tricare, as well as Medicaid and Medicare.
We’re here to make treatment more affordable and less stressful. Our team takes care of prior authorizations and benefits verification for you, and we’ll personally guide you through copay assistance and foundation support programs to help lower your out-of-pocket costs.
How much does Ocrevus® cost?
Ocrevus® cost can vary depending on several factors including insurance status and insurance provider. Our team at Rocky Mountain MS Clinic are committed to lowering costs and improving access for our patients.
We work with virtually all leading commercial insurance providers in the greater Intermountain region, including Aetna, Anthem, Blue Cross Blue Shield, Cigna, DMBA, EMI Health, Humana, PEHP Health & Benefits, Select Health, as Tricare, as well as Medicaid and Medicare.
We’re here to make treatment more affordable and less stressful. Our team takes care of prior authorizations and benefits verification for you, and we’ll personally guide you through copay assistance and foundation support programs to help lower your out-of-pocket costs.
Why Patients Choose Rocky Mountain Infusion Center to Receive Their Ocrevus® Infusion:
Clinical Excellence and Neurological Expertise
Our infusion center is proud to have a board-certified neurologist on-site, along with a team of BSN-prepared and Multiple Sclerosis-certified Registered Nurses, all committed to delivering the highest standard of care for our patients.
Lower Costs and Financial Assistance
We handle prior-authorization, benefits verification, and guide patients through copay assistance and foundation programs to reduce out-of-pocket costs. Additional financial help may be available if you qualify — just ask, and we’ll help you explore every option.
A Cigna report recently found that with a physician-owned infusion site, like RMMSC’s Infusion Center, patients see much lower out-of-pocket and overall costs than they would at a hospital outpatient infusion center.
Important Info
Multiple Sclerosis
Primary Progressive Multiple Sclerosis
Ocrevus® (ocrelizumab): Approved on March 28, 2017
Genentech (a subsidiary of Roche)